Effect of Shatyadi Churna and Hridradi dhoompana in tamak shwas(Bronchial Asthma)

To study the clinical role of shatyadi churana and hridrad dhoompana in tamak shwasa w.s.r. Bronchial asthma - Nil

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109271

Enrollment

Registered

2026-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients above the age of 18 years and below 60 years of either sex were included on the basis of clinical sign and symptoms. 2. The subjects with a history for at least one year, non smokers and absence of long term remission of asthma were included in the study. 3. Diseases of the heart and respiratory system, including: Kasa (cough), Shwasa (asthma or dyspnea), Peenasa (chronic rhinitis/sinusitis), Urdhwajatrugata rogas (diseases above the clavicle) 4. Stable patients with no acute or severe systemic illness, and who are: Not debilitated 5. Not currently undergoing panchakarma elimination procedures 6. Good mental alertness and ability to cooperate with the therapy.

Exclusion criteria

Exclusion criteria: 1. The history of pulmonary tuberculosis, pleural effusion, cardiac asthma, Emphysema, bronchial carcinoma, status asthmatics were excluded from the trial. 2. Patient with age less than 18 years and more than 60 years

Design outcomes

Primary

Measure	Time frame
The primary outcome of this study is to evaluate the clinical efficacy of Shatyadi Churna and Hridradi Dhoompana in the management of Tamak Shwasa, which is comparable to bronchial asthma. The study primarily aims to assess the reduction in severity and frequency of cardinal symptoms such as breathlessness (Shwasa), cough (Kasa), wheezing (Ghurghuraka), and chest tightness, along with improvement in pulmonary function parameters like FEV1, FVC, and PEFR.Timepoint: 60 days	—

Measure

Time frame

The primary outcome of this study is to evaluate the clinical efficacy of Shatyadi Churna and Hridradi Dhoompana in the management of Tamak Shwasa, which is comparable to bronchial asthma. The study primarily aims to assess the reduction in severity and frequency of cardinal symptoms such as breathlessness (Shwasa), cough (Kasa), wheezing (Ghurghuraka), and chest tightness, along with improvement in pulmonary function parameters like FEV1, FVC, and PEFR.Timepoint: 60 days

—

Secondary

Measure	Time frame
The secondary outcomes of the study will be assessed on the basis of improvement in subjective clinical features & laboratory parameters. Subjective assessment will include grading of symptoms such as Peenasa (coryza), Ghurghuraka (wheezing), Shwasa (dyspnea), Kasa (cough), Shayanah Shwasa Piditah (orthopnea), difficulty in expectoration, restlessness, dryness of mouth, & relief in sitting posture, using a standard scoring system. These symptoms will be evaluated at baseline, after completion of 60 days of treatment, & during follow-up. In addition, objective laboratory parameters including Hemoglobin (Hb%), Total Leukocyte Count (TLC), Differential Leukocyte Count (DLC), Erythrocyte Sedimentation Rate (ESR), & Total Eosinophil Count (TEC) will be assessed before & after treatment.Timepoint: 60 days	—

Measure

Time frame

The secondary outcomes of the study will be assessed on the basis of improvement in subjective clinical features & laboratory parameters. Subjective assessment will include grading of symptoms such as Peenasa (coryza), Ghurghuraka (wheezing), Shwasa (dyspnea), Kasa (cough), Shayanah Shwasa Piditah (orthopnea), difficulty in expectoration, restlessness, dryness of mouth, & relief in sitting posture, using a standard scoring system. These symptoms will be evaluated at baseline, after completion of 60 days of treatment, & during follow-up. In addition, objective laboratory parameters including Hemoglobin (Hb%), Total Leukocyte Count (TLC), Differential Leukocyte Count (DLC), Erythrocyte Sedimentation Rate (ESR), & Total Eosinophil Count (TEC) will be assessed before & after treatment.Timepoint: 60 days

—

Countries

India

Contacts

Public ContactDr Sudhesh Kumar Bhambu

Sriganganagar college of ayurvedic science and hospital

drskb07@gmail.com9468709698

Outcome results